ZISHEL GROUP was established to R&D, market, and distribute the novel medical technologies for Plastic, Reconstruction, and Aesthetics. In connection with more than 23 international medical chains and +11,450 private clinics, we have the mega-size distribution channels in over 54 countries covered by +35 blockbuster distributors worldwide. The majority of our executives were both educated and trained in the United States. They lead to excellence via unique leadership styles over our staffs and have propitious relationships with internationally recognized professors, physicians, and healthcare professionals worldwide. Our key differentiator is our continued investments for R&D activities under a variety of applications. In the fast-changing healthcare environment, we challenge ourselves to adapt to new trends and lead developments for novel solutions tailored to our clients' needs.